Erratum: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Ca, 2020
6,709 citations recorded by the source corpus.
receptor, PD-1 dominant negative receptor, ex vivo malignant pleural effusion culture system, and wireless pulse-oximetry device.
Subfields: Economics and Econometrics, Oncology, Organizational Behavior and Human Resource Management
View Paper: https://www.semanticscholar.org/paper/df00d522389443b58a58560292df579c6833fbf9
Citations in the corpus
- Immunotherapies for hepatocellular carcinoma (2021, background): “Current efforts in drug development for advancedstage HCC are focused on (1) evaluating additional combination regimens, (2) identifying new targets, (3) exploring novel immunotherapies, including cell therapies, tumour vaccines and oncolytic viruses, and (4) developing predictive biomarkers.”
- Regulated cell death (RCD) in cancer: key pathways and targeted therapies (2022, background): “Despite the continuous improvement of the treatment level of colorectal cancer, there are still a considerable number of advanced patients with postoperative metastasis or patients with metastasis at the initial diagnosis, and most of them involve the liver, lung, peritoneum, and distant lymph nodes”